{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:04:56Z","timestamp":1774368296155,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":293,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.ebr.2019.100342","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T11:32:44Z","timestamp":1572003164000},"page":"100342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized POLG-1 mutation"],"prefix":"10.1016","volume":"12","author":[{"given":"John T.","family":"Bassett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2019.100342_bb0005","unstructured":"Accessdata.fda.gov. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/018081s046_18082s031lbl.pdf. Published 2019. Accessed July 5, 2019."},{"issue":"2","key":"10.1016\/j.ebr.2019.100342_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities. III. U.S. experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology."},{"issue":"s2","key":"10.1016\/j.ebr.2019.100342_bb0015","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia."},{"issue":"3","key":"10.1016\/j.ebr.2019.100342_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","article-title":"Valproic acid hepatic fatalities: a retrospective review","volume":"37","author":"Dreifuss","year":"1987","journal-title":"Neurology."},{"key":"10.1016\/j.ebr.2019.100342_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/lt.21692","article-title":"Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database","volume":"15","author":"Mindikoglu","year":"2009","journal-title":"Liver Transpl"},{"issue":"15","key":"10.1016\/j.ebr.2019.100342_bb0030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ebr.2019.100342_bb0035","article-title":"Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase (POLG1)","author":"McFarland","year":"2009","journal-title":"Case Reports"},{"issue":"11","key":"10.1016\/j.ebr.2019.100342_bb0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/lt.23965","article-title":"Acute liver failure after valproate exposure in patients with POLG1mutations and the prognosis after liver transplantation","volume":"20","author":"Hynynen","year":"2014","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.ebr.2019.100342_bb0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/lt.23988","article-title":"Acute liver failure after valproate exposure: liver transplantation may be indicated beyond childhood","volume":"20","author":"McKiernan","year":"2014","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.ebr.2019.100342_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and l-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J Anal Toxicol"},{"issue":"4","key":"10.1016\/j.ebr.2019.100342_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbalip.2007.01.010","article-title":"Studies on the extra-mitochondrial CoA-ester formation of valproic and \u03944-valproic acids","volume":"1771","author":"Aires","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"5","key":"10.1016\/j.ebr.2019.100342_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jpeds.2010.10.033","article-title":"Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States","volume":"158","author":"Mindikoglu","year":"2011","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ebr.2019.100342_bb0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jpeds.2013.05.036","article-title":"Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes","volume":"163","author":"Lee","year":"2013","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ebr.2019.100342_bb0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10545-012-9581-z","article-title":"Liver transplantation and cell therapies for inborn errors of metabolism","volume":"36","author":"McKiernan","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.ebr.2019.100342_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","article-title":"Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy","volume":"69","author":"Mock","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"7\u20138","key":"10.1016\/j.ebr.2019.100342_bb0080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1345\/aph.1P135","article-title":"l-Carnitine for acute valproic acid overdose: a systematic review of published cases","volume":"44","author":"Perrott","year":"2010","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ebr.2019.100342_bb0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ebr.2019.100342_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","article-title":"POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders","volume":"19","author":"Saneto","year":"2010","journal-title":"Seizure."},{"issue":"4","key":"10.1016\/j.ebr.2019.100342_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MOP.0b013e328306ebb6","article-title":"Disorders of mitochondrial function","volume":"20","author":"Debray","year":"2008","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"10.1016\/j.ebr.2019.100342_bb0100","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology."}],"container-title":["Epilepsy &amp; Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986419301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986419301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:06:25Z","timestamp":1762905985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986419301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"alternative-id":["S2589986419301364"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2019.100342","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized POLG-1 mutation","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2019.100342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100342"}}